CAPSID ASSEMBLY MODULATOR SOLID FORMULATION

The present disclosure is directed to solid oral dosage forms of a capsid assembly inhibitor for the treatment of hepatitis B virus infection. La présente invention concerne des formes posologiques orales solides d'un inhibiteur d'assemblage de capside pour le traitement d'une infecti...

Full description

Saved in:
Bibliographic Details
Main Authors VERSTRAETE, DOMINIQUE JOSIANE W, LENZ, OLIVER, VAN DYCKE, FREDERIC ANNE R, JANSENS, MARIA, ANNE, MICHAEL BERTIL S, SINGH, ABHISHEK, VANDENBOSSCHE, JORIS JOZEF, BALMAIN, CLAIRE ELISABETH, SNOEYS, JAN
Format Patent
LanguageEnglish
French
Published 17.09.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is directed to solid oral dosage forms of a capsid assembly inhibitor for the treatment of hepatitis B virus infection. La présente invention concerne des formes posologiques orales solides d'un inhibiteur d'assemblage de capside pour le traitement d'une infection par le virus de l'hépatite B.
Bibliography:Application Number: CA20203132095